Back to results
US 2019/0099398 A1Published application
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
AssigneeGW Pharma Limited
InventorsWai LIU, Katherine SCOTT, Angus DALGLEISH, Marnie Duncan, Colin Stott
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.
Claims10
1-6. (canceled)
A method for treatment of a brain tumour comprising:
- administering tetrahydrocannabinol (THC) or cannabidiol (CBD), or a combination thereof, to increase radiosensitivity in the treatment of a brain tumour;
- and
- administering radiation therapy.
A method of preparing an extract, wherein the extract comprises tetrahydrocannabinol (THC) or cannabidiol (CBD), or a combination thereof, the method comprising:
- extracting tetrahydrocannabinol (THC) or cannabidiol (CBD), or a combination thereof, from a cannabis plant to obtain an extract;
- and
- purifying the extract to such an extent that substantially all secondary and minor cannabinoids and non-cannabinoid fractions have been removed.
Dependencies are inferred from the claim text.